These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30773367)

  • 21. Eukaryotic elongation factor 2 kinase confers tolerance to stress conditions in cancer cells.
    Zhu H; Yang X; Liu J; Zhou L; Zhang C; Xu L; Qin Q; Zhan L; Lu J; Cheng H; Sun X
    Cell Stress Chaperones; 2015 Mar; 20(2):217-20. PubMed ID: 25248493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A decrease in eukaryotic elongation factor 2 phosphorylation is required for local translation of sensorin and long-term facilitation in Aplysia.
    McCamphill PK; Ferguson L; Sossin WS
    J Neurochem; 2017 Jul; 142(2):246-259. PubMed ID: 28345161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compartment-specific, differential regulation of eukaryotic elongation factor 2 and its kinase within Aplysia sensory neurons.
    Weatherill DB; McCamphill PK; Pethoukov E; Dunn TW; Fan X; Sossin WS
    J Neurochem; 2011 Jun; 117(5):841-55. PubMed ID: 21426346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emodin inhibits coxsackievirus B3 replication via multiple signalling cascades leading to suppression of translation.
    Zhang HM; Wang F; Qiu Y; Ye X; Hanson P; Shen H; Yang D
    Biochem J; 2016 Feb; 473(4):473-85. PubMed ID: 26621875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myostatin inhibits eEF2K-eEF2 by regulating AMPK to suppress protein synthesis.
    Deng Z; Luo P; Lai W; Song T; Peng J; Wei HK
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):278-284. PubMed ID: 29024627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of eEF2 phosphorylation alleviates synaptic failure and cognitive deficits in mouse models of Down syndrome.
    Wang X; Yang Q; Zhou X; Keene CD; Ryazanov AG; Ma T
    Alzheimers Dement; 2024 Aug; 20(8):5357-5374. PubMed ID: 38934363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eukaryotic elongation factor 2 kinase promotes angiogenesis in hepatocellular carcinoma via PI3K/Akt and STAT3.
    Zhou Y; Li Y; Xu S; Lu J; Zhu Z; Chen S; Tan Y; He P; Xu J; Proud CG; Xie J; Shen K
    Int J Cancer; 2020 Mar; 146(5):1383-1395. PubMed ID: 31286509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Mechanism for the Control of Eukaryotic Elongation Factor 2 Kinase by pH: Role in Cancer Cell Survival.
    Xie J; Mikolajek H; Pigott CR; Hooper KJ; Mellows T; Moore CE; Mohammed H; Werner JM; Thomas GJ; Proud CG
    Mol Cell Biol; 2015 May; 35(10):1805-24. PubMed ID: 25776553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylation of eukaryotic elongation factor 2 (eEF2) by cyclin A-cyclin-dependent kinase 2 regulates its inhibition by eEF2 kinase.
    Hizli AA; Chi Y; Swanger J; Carter JH; Liao Y; Welcker M; Ryazanov AG; Clurman BE
    Mol Cell Biol; 2013 Feb; 33(3):596-604. PubMed ID: 23184662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases.
    Liu R; Proud CG
    Acta Pharmacol Sin; 2016 Mar; 37(3):285-94. PubMed ID: 26806303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SunRiSE - measuring translation elongation at single-cell resolution by means of flow cytometry.
    Argüello RJ; Reverendo M; Mendes A; Camosseto V; Torres AG; Ribas de Pouplana L; van de Pavert SA; Gatti E; Pierre P
    J Cell Sci; 2018 May; 131(10):. PubMed ID: 29700204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation.
    Delaidelli A; Negri GL; Jan A; Jansonius B; El-Naggar A; Lim JKM; Khan D; Oo HZ; Carnie CJ; Remke M; Maris JM; Leprivier G; Sorensen PH
    Cell Death Differ; 2017 Sep; 24(9):1564-1576. PubMed ID: 28574509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological eEF2K activation promotes cell death and inhibits cancer progression.
    De Gassart A; Demaria O; Panes R; Zaffalon L; Ryazanov AG; Gilliet M; Martinon F
    EMBO Rep; 2016 Oct; 17(10):1471-1484. PubMed ID: 27572820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles.
    Kenney JW; Moore CE; Wang X; Proud CG
    Adv Biol Regul; 2014 May; 55():15-27. PubMed ID: 24853390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eukaryotic elongation factor-2 (eEF2): its regulation and peptide chain elongation.
    Kaul G; Pattan G; Rafeequi T
    Cell Biochem Funct; 2011 Apr; 29(3):227-34. PubMed ID: 21394738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On why decreasing protein synthesis can increase lifespan.
    Hipkiss AR
    Mech Ageing Dev; 2007; 128(5-6):412-4. PubMed ID: 17452047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target.
    Karakas D; Ozpolat B
    J Mol Med (Berl); 2020 Jun; 98(6):775-787. PubMed ID: 32377852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. eEF2K inhibition blocks Aβ42 neurotoxicity by promoting an NRF2 antioxidant response.
    Jan A; Jansonius B; Delaidelli A; Somasekharan SP; Bhanshali F; Vandal M; Negri GL; Moerman D; MacKenzie I; Calon F; Hayden MR; Taubert S; Sorensen PH
    Acta Neuropathol; 2017 Jan; 133(1):101-119. PubMed ID: 27752775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Eukaryotic elongation factor 2 kinase and cancer].
    Wang GZ; Qi X; Li J
    Yao Xue Xue Bao; 2015 Jul; 50(7):808-13. PubMed ID: 26552140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer.
    Wang X; Xie J; Proud CG
    Cancers (Basel); 2017 Nov; 9(12):. PubMed ID: 29186827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.